Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials
Abstract Background Obesity is a major health concern for breast cancer survivors, being associated with high recurrence and reduced efficacy during cancer treatment. Metformin treatment is associated with reduced breast cancer incidence, recurrence and mortality. To better understand the underlying...
Main Authors: | Federica Bellerba, Anastasia Chrysovalantou Chatziioannou, Paniz Jasbi, Nivonirina Robinot, Pekka Keski-Rahkonen, Amarine Trolat, Béatrice Vozar, Sheri J. Hartman, Augustin Scalbert, Bernardo Bonanni, Harriet Johansson, Dorothy D. Sears, Sara Gandini |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-022-03809-6 |
Similar Items
-
Metabolic Signatures of 10 Processed and Non-processed Meat Products after In Vitro Digestion
by: Roland Wedekind, et al.
Published: (2020-07-01) -
Untargeted Metabolomics Reveals Major Differences in the Plasma Metabolome between Colorectal Cancer and Colorectal Adenomas
by: Tanja Gumpenberger, et al.
Published: (2021-02-01) -
Commentary: Data Processing Thresholds for Abundance and Sparsity and Missed Biological Insights in an Untargeted Chemical Analysis of Blood Specimens for Exposomics
by: Pekka Keski-Rahkonen, et al.
Published: (2022-01-01) -
Impact of short-term traffic-related air pollution on the metabolome – Results from two metabolome-wide experimental studies
by: Karin van Veldhoven, et al.
Published: (2019-02-01) -
Probabilistic Condition Monitoring of Azimuth Thrusters Based on Acceleration Measurements
by: Riku-Pekka Nikula, et al.
Published: (2021-02-01)